Invasive Ductal Carcinoma Survival Rates The American Cancer Society's 5-year survival rates for breast cancer in the United States are based on how far the cancer has spread: Localized IDC, meaning the cancer has not spread outside the breast: nearly 100% ...
What is the survival rate of invasive ductal carcinoma? Invasive ductal carcinoma describes the type of tumor in about 80 percent of people with breast cancer. The five-year survival rate is quite high --almost 100 percent when the tumor is caught and treated early. How long can you live w...
two-year survival rateinvasive ductal carcinomatumour markersThe aim of this work was to study the status of the human epidermal growth factor receptor 2 (HER2), the oestrogen receptor (ER) and the progesterone receptor (PR) in the south-eastern region of Romania, in the population that was ...
two-year survival rateinvasive ductal carcinomatumour markersThe aim of this work was to study the status of the human epidermal growth factor receptor 2 (HER2), the oestrogen receptor (ER) and the progesterone receptor (PR) in the south-eastern region of Romania, in the population that was ...
PURPOSE: The use of mammographic screening has led to the early detection of breast cancers as well as the increasing incidence of ductal carcinoma in situ (DCIS) and DCIS with microinvasion (MI). The biologic behaviors and management of DCIS and DCIS with MI remain uncertain and controversial...
Ductal carcinoma in situ (DCIS) represents pre-invasive breast carcinoma. In untreated cases, 25–60% DCIS progress to invasive ductal carcinoma (IDC). The challenge lies in distinguishing between non-progressive and progressive DCIS, often resulting in
CONCLUSIONS: DCIS is a favorable disease with an excellent long-term survival. The locoregional recurrence rate in patients with DCIS treated with BCT is similar to that in patients with early-stage invasive breast cancer treated with BCT, but time to locoregional recurrence is significantly longer ...
However, there is controversy regarding whether the definition of pCR should exclude or permit the presence of residual ductal carcinoma in situ (DCIS). Objective To examine the association of residual DCIS in surgical specimens after neoadjuvant chemotherapy for breast cancer with survival end points ...
Ductal carcinoma in situ (DCIS) is a non-obligate precursor to invasive breast cancer (IBC). Studies have indicated differences in DCIS outcome based on race or ethnicity, but molecular differences have not been investigated. We examined the molecular pr
展开 关键词: Humans Carcinoma, Ductal, Breast Carcinoma in Situ Breast Neoplasms Neoplasm Recurrence, Local Survival Rate Retrospective Studies Radiotherapy, High-Energy Mastectomy, Segmental Adult DOI: 10.1016/S0959-8049(97)00137-8 被引量: 100 年份: 1997 收藏...